181 related articles for article (PubMed ID: 19745069)
1. Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells.
Sharma S; Lichtenstein A
Blood; 2009 Nov; 114(19):4179-85. PubMed ID: 19745069
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors.
Jordaan G; Liao W; Sharma S
BMC Cancer; 2013 Feb; 13():88. PubMed ID: 23432814
[TBL] [Abstract][Full Text] [Related]
3. Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia.
Moskalev EA; Luckert K; Vorobjev IA; Mastitsky SE; Gladkikh AA; Stephan A; Schrenk M; Kaplanov KD; Kalashnikova OB; Pötz O; Joos TO; Hoheisel JD
BMC Cancer; 2012 Jun; 12():213. PubMed ID: 22672427
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.
Wang L; Shalek AK; Lawrence M; Ding R; Gaublomme JT; Pochet N; Stojanov P; Sougnez C; Shukla SA; Stevenson KE; Zhang W; Wong J; Sievers QL; MacDonald BT; Vartanov AR; Goldstein NR; Neuberg D; He X; Lander E; Hacohen N; Regev A; Getz G; Brown JR; Park H; Wu CJ
Blood; 2014 Aug; 124(7):1089-98. PubMed ID: 24778153
[TBL] [Abstract][Full Text] [Related]
7. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
Chim CS; Pang R; Liang R
J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors.
Laux H; Tomer R; Mader MT; Smida J; Budczies J; Kappler R; Hahn H; Blöchinger M; Schnitzbauer U; Eckardt-Schupp F; Höfler H; Becker KF
Lab Invest; 2004 Oct; 84(10):1372-86. PubMed ID: 15311212
[TBL] [Abstract][Full Text] [Related]
11. The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers.
Karam R; Carvalho J; Bruno I; Graziadio C; Senz J; Huntsman D; Carneiro F; Seruca R; Wilkinson MF; Oliveira C
Oncogene; 2008 Jul; 27(30):4255-60. PubMed ID: 18427545
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.
Billot K; Soeur J; Chereau F; Arrouss I; Merle-Béral H; Huang ME; Mazier D; Baud V; Rebollo A
Blood; 2011 Feb; 117(6):1917-27. PubMed ID: 21139082
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options.
Gandhirajan RK; Poll-Wolbeck SJ; Gehrke I; Kreuzer KA
Curr Cancer Drug Targets; 2010 Nov; 10(7):716-27. PubMed ID: 20578984
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of Protocadherin-alpha transcripts are decreased by nonsense-mediated mRNA decay with frameshift mutations and by high DNA methylation in their promoter regions.
Kaneko R; Kawaguchi M; Toyama T; Taguchi Y; Yagi T
Gene; 2009 Feb; 430(1-2):86-94. PubMed ID: 19038318
[TBL] [Abstract][Full Text] [Related]
15. Transcripts expressed using a bicistronic vector pIREShyg2 are sensitized to nonsense-mediated mRNA decay.
Shikama Y; Hu H; Ohno M; Matsuoka I; Shichishima T; Kimura J
BMC Mol Biol; 2010 Jun; 11():42. PubMed ID: 20513249
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
Kuphal F; Behrens J
Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin gene mutations in human gastric carcinoma cell lines.
Oda T; Kanai Y; Oyama T; Yoshiura K; Shimoyama Y; Birchmeier W; Sugimura T; Hirohashi S
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1858-62. PubMed ID: 8127895
[TBL] [Abstract][Full Text] [Related]
18. Aberrant splicing in B-cell acute lymphoblastic leukemia.
Black KL; Naqvi AS; Asnani M; Hayer KE; Yang SY; Gillespie E; Bagashev A; Pillai V; Tasian SK; Gazzara MR; Carroll M; Taylor D; Lynch KW; Barash Y; Thomas-Tikhonenko A
Nucleic Acids Res; 2018 Nov; 46(21):11357-11369. PubMed ID: 30357359
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors.
Howng SL; Wu CH; Cheng TS; Sy WD; Lin PC; Wang C; Hong YR
Cancer Lett; 2002 Sep; 183(1):95-101. PubMed ID: 12049819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
